A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin-Reference-Cited by-同舟云学术

A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin

Published:2016-10-13 Issue:3 Volume:33 Page:e2858
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Raccah Denis¹,Chou Engels²,Colagiuri Stephen³,Gaàl Zsolt⁴,Lavalle Fernando⁵,Mkrtumyan Ashot⁶,Nikonova Elena⁷,Tentolouris Nikolaos⁸,Vidal Josep⁹,Davies Melanie¹⁰

Affiliation:

1. Department of Diabetology; University Hospital Sainte-Marguerite; Marseille France

2. Sanofi R&D; Bridgewater NJ USA

3. Boden Institute; University of Sydney; Camperdown NSW Australia

4. Department of Medicine; András Jósa Teaching Hospital; Nyíregyháza Hungary

5. Servicio de Endocrinología, Facultad de Medicina UANL; Hospital Universitario; Monterrey NL Mexico

6. Moscow State Medical and Stomatological University named after Evdokimov; Moscow Russian Federation

7. Sanofi Global Medical Affairs; Bridgewater NJ USA

8. University of Athens Medical School; Athens Greece

9. Endocrinology and Nutrition Department; Hospital Clinic; Barcelona Spain

10. Diabetes Research Centre; University of Leicester; Leicester United Kingdom

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference50 articles.

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;UK Prospective Diabetes Study Group;Lancet,1998

2. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

3. Global guideline for type 2 diabetes;International Diabetes Federation Guideline Development Group;Diabetes Res Clin Pract,2014

4. Standards of care: approaches to glycemic treatment;American Diabetes Association;Diabetes Care,2015

5. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress in Glucose-Responsive Insulin;Diabetes;2024-06-10

2. The effects of transcription factor 7-like 2 rs7903146 and paired box 4 rs2233580 variants associated with type 2 diabetes on the therapeutic efficacy of hypoglycemic agents;Heliyon;2024-03

3. Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U‐100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring;Journal of Diabetes Investigation;2024-01-23

4. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa;Endocrine Reviews;2024-01-16

5. Factors affecting unmet medical needs of patients with diabetes: A population‐based study;Nursing Open;2023-07-17